Indeed, certain TPC2 polymorphisms appear to be correlated with bone mineral density (G734E, loss-of-inhibition) [35] and inversely correlate with type 2 diabetes mellitus (M484L, gain-of-function) [36], conditions previously associated with TPC2 function [23–25,37]. Here, TPCN2 is linked to type 2 diabetes mellitus.